October 29th 2024
The CANOPY Phase 3 clinical trial demonstrated a reduced risk of symptomatic COVID-19, including a 64% reduction during the off-drug follow-up period.
October 29th 2024
Shionogi’s ensitrelvir demonstrated reduction of symptoms in phase 3 trial.
October 24th 2024
Important vaccine updates, including a second COVID-19 vaccine dose for adults 65 and older and immunocompromised individuals, a pneumococcal vaccine for adults aged 50 and older, and more.
October 11th 2024
A NIH-funded study focused on analyzing the Wuhan strain in unvaccinated patients with COVID-19. Results showed those with certain blood types seemed to fare worse significantly increasing their risk for cardiovascular events and mortality.
October 11th 2024
Despite evidence of their effectiveness in reducing hospitalization and mortality rates, many older individuals remain untreated, with recent studies highlighting significant disparities in treatment access and adherence.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Similar Rates of Mortality Seen in Hospitalized COVID-19 Patients with Chronic Inflammatory Diseases
April 2nd 2021Hospitalized patients with COVID-19 and chronic inflammatory diseases were seen to have no statistically significant increased length of hospital stay or need for mechanical ventilation.
Read More
Canada Recommends Not Using AstraZeneca COVID-19 Vaccines in People 55 and Younger
March 30th 2021The country’s federal health agency decided upon this action based on the small number of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) incidents in Europe, which are being investigated.
Read More
New Modeling Suggests Optimal Airplane Seating to Limit COVID-19 Transmission
March 30th 2021The coronavirus disease 2019 pandemic hurt the bottom lines of airlines, as the public worried air travel would expose them to catching the virus. A new analysis suggests how airlines can best mitigate that risk.
Read More
Escalated Anticoagulation Shows No Benefit Over Standard Dosing for COVID-19 Patients in ICU
March 29th 2021Intermediate-dose prophylactic anticoagulation did not improve mortality or venous or arterial thrombosis in patients with COVID-19 in the ICU compared with standard dosing, a new study found.
Read More
2 Commerce Drive
Cranbury, NJ 08512